Immunology Research
Reaching New Understandings of Disease States
Involved with Phase I - IV clinical trials, our immunology research team is constantly exploring a broad range of therapeutic and pathogenic states. Our experienced team of clinical researchers looks at different therapeutics that have the potential to improve outcomes for patients suffering from conditions such as:
- Ankylosing spondylitis
- Gout
- Osteoarthritis
- Psoriatic arthritis
- Rheumatoid arthritis
- Sjogren’s syndrome
Throughout the course of our work, our researchers and partners benefit from seeing a full range of patients, from those in early stages of disease to established disease.
Increasing the Odds of Success for Partners
By partnering with our immunology research team, industry sponsors, government organizations and academic medical centers increase their chance of research success when attempting to answer relevant questions about diseases. This success is driven by:
- Resources of a large academic medical center that functions like a smaller community hospital
- Access to immunologists and other research staff who have a high level of expertise and experience in clinical trials
- Fast and effective patient enrollment driven through high-quality practices
Helping Patients Beyond Atrium Health
Because of the immunological research being conducted at Atrium Health, patients are often referred here to obtain access to novel compounds and therapeutic agents that are not otherwise available. This allows the patient to maintain their local physician as their primary physician while participating in a study with our immunologists to potentially improve their quality of life.